CLASS II Device recall · Reported 19 Jun 2019 · FDA Enforcement Report

Silhouette VR This fully integrated system offers intuitive recalled

GE Healthcare is recalling Silhouette VR This fully integrated system offers intuitive controls with advanced, distributed nationwide in the US. The recall was initiated on 29 Mar 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesDZ1061RX02 and UP389014.
Quantity recalled825 (38 US and 787 OUS) in total

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1755-2019
FDA event ID
82668
Recalling firm
GE Healthcare, Waukesha, WI
Classification
Class II
Status
Terminated
Recall initiated
29 Mar 2019
FDA classified
10 Jun 2019
Reported
19 Jun 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

29 Mar 2019Recall initiated by company
10 Jun 2019Classified by FDA+73 days
19 Jun 2019Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There has been a reported incident of a Distar CRT monitor that has fallen off the monitor wall mount related to product aging.

Product as listed by the FDA

Silhouette VR This fully integrated system offers intuitive controls with advanced applications for maximum performance all in a space-saving design.

Where it was distributed

Worldwide Distribution: US (nationwide) to states of: AL, CA, CT, FL, GA, HI, IL, LA, MD, MI, MN, MO, NH, NY, OK, PA, TN, and VA; and countries of: Algeria, Argentina, Belgium, Bosnia & Herzegovina, Brazil, Bulgaria, Canada, China, Costa Rica, Cote D'Ivoire, Cyprus, Czech Republic, Egypt , France, French Polynesia, Germany, Greece, Guadeloupe, Guyana, Hungary, Italy, Japan, Korea, Lebanon, Mexico, Morocco, New Caledonia, Norway , Poland, Portugal, Russia, Saudi Arabia,Slovakia, Spain, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom, Venezuela, and Vietnam.

Nationwide AlabamaCaliforniaConnecticutFloridaGeorgiaHawaiiIllinoisLouisianaMarylandMichiganMinnesotaMissouriNew HampshireNew YorkOklahomaPennsylvaniaTennesseeVirginia

Questions about this recall

Why was it recalled?

There has been a reported incident of a Distar CRT monitor that has fallen off the monitor wall mount related to product aging.

Which lots are affected?

DZ1061RX02 and UP389014.

Where was it sold?

Worldwide Distribution: US (nationwide) to states of: AL, CA, CT, FL, GA, HI, IL, LA, MD, MI, MN, MO, NH, NY, OK, PA, TN, and VA; and countries of: Algeria, Argentina, Belgium, Bosnia & Herzegovina, Brazil, Bulgaria, Canada, China, Costa Rica, Cote D'Ivoire, Cyprus, Czech Republic, Egypt , France, French Polynesia, Germany, Greece, Guadeloupe, Guyana, Hungary, Italy, Japan, Korea, Lebanon, Mexico, Morocco, New Caledonia, Norway , Poland, Portugal, Russia, Saudi Arabia,Slovakia, Spain, Taiwan, Tunisia, Turkey, Ukraine, United Kingdom, Venezuela, and Vietnam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 82668

This product is part of a recall event; the main page for the event is Prestilix 1600X Prestilix system is a fully integrated recalled.

More recalls from GE Healthcare

All 512

Other Other Medical Devices recalls

All 13,778